# Clinical Study to Determine Bioequivalence Between Two Oral Medications of Empagliflozin/Metformin in 12.5 mg / 1000 mg Tablets Under Fed Conditions.

> **NCT07633041** · NA · COMPLETED · sponsor: **ADIUM** · enrollment: 42 (actual)

## Conditions studied

- Bioequivalence Study in Healthy Subjects

## Interventions

- **DRUG:** Synjardy 12.5/1000 mg tablet
- **DRUG:** Empagliflozin/metformin 12.5/1000 mg

## Key facts

- **NCT ID:** NCT07633041
- **Lead sponsor:** ADIUM
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2025-02-05
- **Primary completion:** 2025-04-04
- **Final completion:** 2025-04-04
- **Target enrollment:** 42 (ACTUAL)
- **Last updated:** 2026-06-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07633041

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07633041, "Clinical Study to Determine Bioequivalence Between Two Oral Medications of Empagliflozin/Metformin in 12.5 mg / 1000 mg Tablets Under Fed Conditions.". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07633041. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*